ATNM icon

Actinium Pharmaceuticals
ATNM

Overview Fund Activity

24 hedge funds and large institutions have $8.12M invested in Actinium Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
6
Closed
8
Calls
$62K
Puts
$221K
Net Calls
-$159K
Net Calls Change
-$56K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.65M
2
OAM
2
Oxford Asset Management
United Kingdom
$378K
3
BIT
3
BlackRock Institutional Trust
California
$1.34M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$312K
5
DADC
5
D.A. Davidson & Co
Montana
$161K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
DCM
3
DAFNA Capital Management
California
$0
4
SM
4
Sabby Management
Florida
$0
5
VKH
5
Virtu KCG Holdings
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
– – -95,335 Closed
DCM
27
DAFNA Capital Management
California
– – -90,000 Closed
SM
28
Sabby Management
Florida
– – -68,427 Closed
VKH
29
Virtu KCG Holdings
New York
– – -52,783 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– – -7,416 Closed
Simplex Trading
31
Simplex Trading
Illinois
– – -5,986 Closed
BJ
32
BlackRock Japan
Japan
– – -2,247 Closed
1
2